Condensed Consolidated Statement of Cash Flows (Unaudited) (USD $)	9 Months Ended		167 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (18,456,004)	$ (640,033)	$ (31,843,045)
Adjustments to reconcile net loss to net cash used in operating activities
Fair value of options issued in exchange for services	8,427,202	11,638	10,844,434
Accretion of interest on deferred finance charges		12,562	453,625
Accretion of discount on notes payable	3,718	3,717	446,954
Change in fair value warrant liability	3,104,209		3,104,209
Change in fair value embedded derivative liability	500,000		500,000
Fair value of warrants in excess of consideration for convertible preferred stock	2,995,791		2,995,791
Fair value of stock in excess of converted notes payable and accrued interest	1,221,875		1,221,875
Salary due to stockholder contributed to capital			15,000
Amortization and depreciation	61,339	8,328	591,394
Gain on disposition of assets			(4,722)
Gain on debt forgiveness			(340,352)
Stock issued in exchange for services			553,760
Financing expenses paid directly from stock proceeds			5,270
Amortization of deferred consulting fees			40,800
(Increase) decrease in assets
Accounts receivable		(3,473)	(3,473)
Inventory	(19,454)	3,583	526
Prepaid expenses	420,395	117,760	70,395
Deposit	(37,197)		(37,197)
Increase in liabilities
Accounts payable and accrued expenses	(230,516)	298,584	2,336,846
Net cash used in operating activities	(2,008,642)	(187,334)	(9,047,910)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(10,573)		(48,682)
Purchase of patents and trademarks	(21,954)	(2,406)	(246,088)
Proceeds from sale of assets			6,738
Net cash used in investing activities	(32,527)	(2,406)	(288,032)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of preferred stock	1,000,000		1,000,000
Proceeds from issuance of common stock	235,000		6,786,447
Proceeds from exercise of stock options	17,919		273,401
Proceeds issuance of stock options			15,000
Proceeds from exercise of warrants	10,000		115,500
Proceeds from issuance of warrants			1,000,000
Proceeds from issuance of notes payable		200,000	2,789,000
Repayments of notes payable			(202,751)
Payment for treasury stock			(17,795)
Debt issuance costs			(62,000)
Stock issuance costs			(144,760)
Net cash provided by financing activities	1,262,919	200,000	11,552,042
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(778,250)	10,260	2,216,100
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	2,994,350	53,573
CASH AND CASH EQUIVALENTS - END OF PERIOD	2,216,100	63,833	2,216,100
Cash paid during the year for:
Interest	13,895		53,336
Income taxes
Return of shares of common stock related to purchase price adjustment
Common stock			(1,000)
Additional paid-in capital			(353,000)
Intangible assets			(354,000)
Issuance of common stock and stock options for acquisition of subsidiary			738,000
Proceeds from common stock sales applied directly to debt and financing expenses repayment			55,270
Fair value of warrants issued for deferred finance charges			392,376
Fair value of stock issued for conversion of notes payable and accrued interest	668,125		1,561,730
Fair value of stock issued for conversion of preferred stock to common stock	366,667		366,667
Fair value of stock issued for purchase of assets			100,000
Fair value of warrants issued for purchase of assets			100,000
Fair value of stock issued for licensing costs			100,000
Fair value of warrants issued for licensing costs			300,000
Accretion of discount on preferred stock as deemed dividend distribution	1,000,000		1,000,000
Fair value of beneficial conversion feature	1,500,000		1,500,000
Fair value of warrants issued as debt discount			78,043
Issuance of common stock for stock issuance costs			2,100
Issuance of options as stock cost for treasury stock			5,594
Forgiveness of debt-related party treated as additional paid in capital			$ 349,000